Fundamentals and stats

Orexo AB engages in the development of pharmaceuticals based on innovative drug delivery technologies. It operates through the following segments: US Commercial and HQ and Pipelines. The US Commercial segment focuses on marketing and distributing a prescription medication used for opioid dependence treatment in the US. The HQ and Pipeline segment focuses in the out-licensed pharmaceuticals and costs for research and development, business development, global regulatory, and supply chain. The company was founded by Thomas Lundqvist on November 18, 1994 and is headquartered in Uppsala, Sweden.